At NTD we recognize that pregnancy can be a time that raises many health related questions and concerns for your patients. For this reason, we strive to provide a comprehensive portfolio of prenatal screening services that deliver trusted, timely results, in order to better inform and empower both you and your patients.

Leading medical authorities recommend that all pregnant women be offered screening to evaluate the health of their baby and assess the overall health of the pregnancy. We are here to help you provide the best care for your patients.

Woman receiving ultrasound
NTD’s Premier Test:

Maternal Fetal Screen | T1SM

The Most Comprehensive Overall Pregnancy Health Evaluation

Maternal Fetal Screen | T1SM is the only test to combine first-trimester aneuploidy risk assessment with early onset preeclampsia (EOPE) in one report—providing your patient with a comprehensive personalized risk result as early as 10 weeks’ gestation.

By combining ultrasound measurements with the analysis  of five biochemical markers, MFS|T1SM provides increased detection for Down Syndrome, at 98% with a 1.2% false positive rate. It also casts a wide net for other maternal and fetal issues, such as other aneuploidies, preeclampsia, low birth weight, fetal loss, and stillbirth.

Maternal Fetal Screen | T1SM Detection Rates

Down Syndrome

Early onset preeclampsia

Prenatal Test Menu

NTD Eurofins is committed to providing you with best-in-class technology for all of your prenatal screening tests:

Learn more about why NTD Eurofins has been the laboratory to trust for over 30 years.

Learn More

Interested in sending samples?

We can help you get started!

Contact Us for More Information